ConductScience.org, home

Paper22190859

Tumor evasion from T cell surveillance.

Töpfer K and 7 others. J Biomed Biotechnol, 2011. Cited by 129 papers, by iCite.

Cite this record

ConductScience Library. Tumor evasion from T cell surveillance. Papers, record 22190859. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22190859

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor evasion from T cell surveillance.
PubMed
Journal
J Biomed Biotechnol
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
129
iCite
Relative citation ratio, by iCite
2.92
iCite
Revised in PubMed
2021-10-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Töpfer KKatrin
2Kempe SStefanie
3Müller NNadja
4Schmitz MMarc
5Bachmann MMichael
6Cartellieri MMarc
7Schackert GGabriele
8Temme AAchim

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunologic SurveillanceMajor topic
NeoplasmsMajor topic
T-LymphocytesMajor topic
Tumor EscapeMajor topic
Animals
Dendritic Cells
Humans
Immune Tolerance
Neoplasm Proteins
Peptides
Receptors, Antigen, T-Cell

Source PubMed

Download CSV of topics

References215

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117289884FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.Clin Cancer Res2007https://conductscience.org/library/papers/17289884PubMed
29033277Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.Am J Pathol1997https://conductscience.org/library/papers/9033277PubMed
39988230galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas.Int J Cancer1999https://conductscience.org/library/papers/9988230PubMed
47510905Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.Science1994https://conductscience.org/library/papers/7510905PubMed
520498667Cross-priming in health and disease.Nat Rev Immunol2010https://conductscience.org/library/papers/20498667PubMed
611241742Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma.Glia2001https://conductscience.org/library/papers/11241742PubMed
710389764Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72).Int J Cancer1999https://conductscience.org/library/papers/10389764PubMed
817638524Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.Oligonucleotides2007https://conductscience.org/library/papers/17638524PubMed
920467460Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.J Biomed Biotechnol2010https://conductscience.org/library/papers/20467460PubMed
1010023441Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL).Gene Ther1998https://conductscience.org/library/papers/10023441PubMed
1117473204CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients.Clin Cancer Res2007https://conductscience.org/library/papers/17473204PubMed
129636188Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9636188PubMed
1312407407Natural selection of tumor variants in the generation of "tumor escape" phenotypes.Nat Immunol2002https://conductscience.org/library/papers/12407407PubMed
1421436444Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.Science2011https://conductscience.org/library/papers/21436444PubMed
1517873860Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.Nature2007https://conductscience.org/library/papers/17873860PubMed
1617000676Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.Clin Cancer Res2006https://conductscience.org/library/papers/17000676PubMed
1715256471Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.Cancer Res2004https://conductscience.org/library/papers/15256471PubMed
188885869Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice.Immunity1996https://conductscience.org/library/papers/8885869PubMed
1914993030Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer.Ann Surg Oncol2004https://conductscience.org/library/papers/14993030PubMed
2015800326Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.J Clin Oncol2005https://conductscience.org/library/papers/15800326PubMed

See all 215 referencesDownload CSV of references

Cited by84

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
40535484Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges.World J Transplant2025https://conductscience.org/library/papers/40535484PubMed
40156188Immuno-oncology recapitulates ontogeny: Modern cell and gene therapy for cancer.Mol Ther2025https://conductscience.org/library/papers/40156188PubMed
40122853New insights into T cell metabolism in liver cancer: from mechanism to therapy.Cell Death Discov2025https://conductscience.org/library/papers/40122853PubMed
40075663Immune Cell Interplay in the Fight Against GBM.Cancers (Basel)2025https://conductscience.org/library/papers/40075663PubMed
39464313How lactate affects immune strategies in lymphoma.Front Mol Biosci2024https://conductscience.org/library/papers/39464313PubMed
39456240How Do ROS Induce NETosis? Oxidative DNA Damage, DNA Repair, and Chromatin Decondensation.Biomolecules2024https://conductscience.org/library/papers/39456240PubMed
38827239The Evolving Landscape of Biomarkers for Immune Checkpoint Blockade in Genitourinary Cancers.Biomark Insights2024https://conductscience.org/library/papers/38827239PubMed
38673726Advancements in Photothermal Therapy Using Near-Infrared Light for Bone Tumors.Int J Mol Sci2024https://conductscience.org/library/papers/38673726PubMed
38244129CAR-T cell therapy: a game-changer in cancer treatment and beyond.Clin Transl Oncol2024https://conductscience.org/library/papers/38244129PubMed
38067140Chromosomal Instability-Driven Cancer Progression: Interplay with the Tumour Microenvironment and Therapeutic Strategies.Cells2023https://conductscience.org/library/papers/38067140PubMed
37445733Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies.Int J Mol Sci2023https://conductscience.org/library/papers/37445733PubMed
36974661Current Advances and Future Prospects in Cancer Immunotherapeutics.Medeni Med J2023https://conductscience.org/library/papers/36974661PubMed
36840349Epigenetic therapies for neuroblastoma: immunogenicity awakens.Mol Oncol2023https://conductscience.org/library/papers/36840349PubMed
36521927Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch.J Immunother Cancer2022https://conductscience.org/library/papers/36521927PubMed
36358857Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy.Cancers (Basel)2022https://conductscience.org/library/papers/36358857PubMed
36301267Increased CaMKK2 Expression Is an Adaptive Response That Maintains the Fitness of Tumor-Infiltrating Natural Killer Cells.Cancer Immunol Res2023https://conductscience.org/library/papers/36301267PubMed
36139542Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies.Cancers (Basel)2022https://conductscience.org/library/papers/36139542PubMed
36097193Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype.Oncogene2022https://conductscience.org/library/papers/36097193PubMed
35902131Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer.J Immunother Cancer2022https://conductscience.org/library/papers/35902131PubMed
35664303Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer.Front Genet2022https://conductscience.org/library/papers/35664303PubMed

See all 84 cited byDownload CSV of cited by

Genes89

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACP355PubTator's text mininghttps://conductscience.org/library/genes/55NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
BCL2A1597PubTator's text mininghttps://conductscience.org/library/genes/597NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CASP6839PubTator's text mininghttps://conductscience.org/library/genes/839NCBI Gene
CASP7840PubTator's text mininghttps://conductscience.org/library/genes/840NCBI Gene
CCL226367PubTator's text mininghttps://conductscience.org/library/genes/6367NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD247919PubTator's text mininghttps://conductscience.org/library/genes/919NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD40LG959PubTator's text mininghttps://conductscience.org/library/genes/959NCBI Gene
CD80941PubTator's text mininghttps://conductscience.org/library/genes/941NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CEACAM51048PubTator's text mininghttps://conductscience.org/library/genes/1048NCBI Gene

See all 89 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22190859

GET https://conductscience.org/api/papers/v1/22190859/references?page=2